Searchable abstracts of presentations at key conferences in endocrinology

Endocrine Abstracts

Published by BioScientifica
Previous issue | Volume 56 | ECE2018 | Next issue

20th European Congress of Endocrinology

Barcelona, Spain
19 May 2018 - 22 May 2018

Card image cap
ECE 2018, 19 - 22 May 2018; Barcelona, Spain

Poster Presentations: Pituitary and Neuroendocrinology

Pituitary - Clinical

Previous section
Pituitary - Basic
Table of contents

ea0056p788 | Pituitary - Clinical

Sheehan’s syndrome: clinical and laboratory evaluation of 80 cases

ea0056p789 | Pituitary - Clinical

Metabolic and cardiovascular outcome in patients with Sheehan’s syndrome

ea0056p790 | Pituitary - Clinical

Final results of NordiNet® international outcome study: key outcomes

ea0056p791 | Pituitary - Clinical

Relationship between cortisol increment and basal cortisol: implications for the insulin tolerance test in assessing corticotrop insufficiency

ea0056p792 | Pituitary - Clinical

A case of pituitary metastasis in female patient with an invasive breast carcinoma

ea0056p793 | Pituitary - Clinical

Non-classical factors of cardiovascular risk in acromegaly

ea0056p794 | Pituitary - Clinical

A comparison of pituitary function in primary and secondary empty sella: preliminary data

ea0056p795 | Pituitary - Clinical

Thyroid autoimmunity in patients with empty sella syndrome

ea0056p796 | Pituitary - Clinical

Assessment of prevalence and severity of depressive symptoms in patients with acromegaly using the beck depression inventory II (BDI-II) – own observations

ea0056p797 | Pituitary - Clinical

Giant prolactinomas in men: clinical features and therapeutic outcomes

ea0056p798 | Pituitary - Clinical

Static and dynamic balances in acromegaly and impact of exercise on balance

ea0056p799 | Pituitary - Clinical

Severe hypernatremia resulting in a locked-in syndrome

ea0056p800 | Pituitary - Clinical

Thyroid autoimmunity and euthyroid hashimoto thyroiditis frequancy in patients with pituitary adenoma

ea0056p801 | Pituitary - Clinical

Gonadotroph pituitary macroadenoma inducing ovarian hyperstimulation syndrome

ea0056p802 | Pituitary - Clinical

Associated pituitary insufficiencies in children with growth hormone deficiency

ea0056p803 | Pituitary - Clinical

Metastasis – A rare cause of diabetes insipidus and pituitary insufficiency

ea0056p804 | Pituitary - Clinical

Endocrine abnormalities in primary empty sella syndrome

ea0056p805 | Pituitary - Clinical

Long-term outcomes of different treatments for cushing disease: a retrospective study

ea0056p806 | Pituitary - Clinical

Association between prolactin level and tumor size reduction at 3 months after cabergoline treatment in patients with macroprolactinoma

ea0056p807 | Pituitary - Clinical

Predictors of clinical behavior of pituitary adenomas

ea0056p808 | Pituitary - Clinical

The comparison of combination test either with 1 μg acth test and glucagon test for the evaluation of hypothalamo-pituitary-adrenal axis in patients with pituitary disorders

ea0056p809 | Pituitary - Clinical

Clinical parameters to distinguish silent corticotroph adenomas from other non-functioning pituitary adenomas

ea0056p810 | Pituitary - Clinical

Male hypogonadism – when two endocrine causes merge in the same patient

ea0056p811 | Pituitary - Clinical

The diagnostic utility of late night salivary cortisol (LNSF) and cortisone (LNSE) in Cushing’s Syndrome and their relationship to metabolic markers

ea0056p812 | Pituitary - Clinical

Is elevated urotensin II level a predictor for increased cardiovascular risk in subjects with acromegaly?

ea0056p813 | Pituitary - Clinical

The association between Ki-67 proliferation index, P53 expression, mitotic index, tumor invasion and the risk of recurrence in pituitary adenomas

ea0056p814 | Pituitary - Clinical

Pituitary enlargement due to the autoimmune thyroiditis mimicking a pituitary macroadenoma

ea0056p815 | Pituitary - Clinical

Intracranial germinoma with panhypopituitarism in a 18-year old patient

ea0056p816 | Pituitary - Clinical

Primary pituitary abscess: an unexpected diagnosis

ea0056p817 | Pituitary - Clinical

Diurnal melatonin profile in patients with pituitary adenomas

ea0056p818 | Pituitary - Clinical

Diabetes insipidus due to hypothalamitis and infundibulo-neurohypophysitis

ea0056p819 | Pituitary - Clinical

Age and severity of hyperthyroidism are determinants of thoracic vertebral fractures in patients with TSH-secreting pituitary adenoma

ea0056p820 | Pituitary - Clinical

Cushing disease after remission and prevalence of cardiovascular risk factors

ea0056p821 | Pituitary - Clinical

Clinical relevance of metabolic phenotype in hypopituitarism: what really matters?

ea0056p822 | Pituitary - Clinical

TSH-secreting pituitary adenomas: clinical and morphological characteristics and outcomes of surgical treatment

ea0056p823 | Pituitary - Clinical

Recovery of the adrenal function after pituitary surgery in patients with Cushing Disease: remission or recurrence?

ea0056p824 | Pituitary - Clinical

Hypothalamic involvement in diffuse large B-celllymphoma

ea0056p825 | Pituitary - Clinical

Iceberg alert: undetected health problems in adults with Prader-Willi syndrome – multidisciplinary care could prevent ‘unexplained deaths’

ea0056p826 | Pituitary - Clinical

Pituitary apoplexy in pregnancy lead to empty sella

ea0056p827 | Pituitary - Clinical

Benefits of pre-surgical treatment with somatostatin analogs in naive patients with acromegaly

ea0056p828 | Pituitary - Clinical

Temozolomide is effective for rapid control of hypercortisolism in aggressive acth-secreting pituitary tumors

ea0056p829 | Pituitary - Clinical

Cancer in acromegaly: a case-control study

ea0056p830 | Pituitary - Clinical

A rare case of acromegaly with normal IGF-1, severe chronic congestive heart failure, and impaired glucose tolerance

ea0056p831 | Pituitary - Clinical

Two-dimensional speckle tracking echocardiography showed a slight impairment of left ventricular deformability in acromegalic patients at diagnosis and during follow-up

ea0056p832 | Pituitary - Clinical

Trabecular bone score as skeletal fragility predictor in patients with acromegaly

ea0056p833 | Pituitary - Clinical

Registry for central diabetes insipidus in Russia: prevalence and etiologies of the disease

ea0056p834 | Pituitary - Clinical

Two cases of silent corticotroph adenomas

ea0056p835 | Pituitary - Clinical

IgG4-related neuroinfundibulo-hypophysitis treated by rituximab and corticosteroids

ea0056p836 | Pituitary - Clinical

Early postsurgery cortisol after transphenoidal surgery to predict adrenal insufficiency one year posturgery

ea0056p837 | Pituitary - Clinical

Cushing’s disease with negative or inconclusive MRI: reassessment of transphenoidal surgery at the age of medical treatment. Post operative remission rate in 184 patients including 86 with negative or inconclusive MRI

ea0056p838 | Pituitary - Clinical

Simultaneous coexistence of Cushing’s disease and renal cell carcinoma

ea0056p839 | Pituitary - Clinical

The relationship between sleep apnea syndrome and metabolic parameters in patients with acromegaly

ea0056p840 | Pituitary - Clinical

Early postoperative GH level as biomarker for surgical outcome in patients with acromegaly

ea0056p841 | Pituitary - Clinical

Optimal follow-up strategy based on the natural history of nonfunctioning pituitary adenomas

ea0056p842 | Pituitary - Clinical

Thicknesses of Chorioretinal layers in Prolactinoma Patients: A Spectral Domain Optical Coherence Tomography Study

ea0056p843 | Pituitary - Clinical

Combined treatment of craniopharyngiomas

ea0056p844 | Pituitary - Clinical

Vitamin D status in acromegaly: a comparative study

ea0056p845 | Pituitary - Clinical

Hypernatraemia and mental disorders

ea0056p846 | Pituitary - Clinical

The use of colonoscopic screening in acromegaly in our everyday practice revisited: how compliant with guidelines have we been?

ea0056p847 | Pituitary - Clinical

The Secret of the Ophtalmopathy

ea0056p848 | Pituitary - Clinical

Tolvaptan usage in hyponatremic patients with syndrome of inappropriate secretion of antidiuretic hormone: a single-center experience

ea0056p849 | Pituitary - Clinical

Real-world data from NordiNet International Outcome Study (IOS) and ANSWER Program provide new insights into the safety of growth hormone in a large cohort of children with Noonan Syndrome

ea0056p850 | Pituitary - Clinical

Hypophysitis: Experience of a single tertiary center

ea0056p851 | Pituitary - Clinical

Pituitary adenomas in childhood and the transition period - clinical and genetic characterization of 49 patients at one tertiary care endocrine institution in Romania

ea0056p852 | Pituitary - Clinical

Psychopathology in Cushing’s disease and acromegaly

ea0056p853 | Pituitary - Clinical

Presence of empty sella in a patient with clinical and biochemical diagnosis of acromegaly

ea0056p854 | Pituitary - Clinical

The metabolic disturbances in acromegaly patients in relation to total, acylated and unacylated ghrelin

ea0056p855 | Pituitary - Clinical

Hypopituitarism in primary empty sella

ea0056p856 | Pituitary - Clinical

A first-in-human pharmacokinetic, safety, and tolerability study of pasireotide subcutaneous depot

ea0056p857 | Pituitary - Clinical

HLA celiac haplotypes and Primary Autoimmune Hypophysitis in Caucasian patients

ea0056p858 | Pituitary - Clinical

Consensus on the management of acromegaly in Spain

ea0056p859 | Pituitary - Clinical

PROMPT: a prospective study to assess efficacy and safety of metyrapone in endogenous Cushing’s syndrome

ea0056p860 | Pituitary - Clinical

Mind the gap between cortisol levels measured with second generation assays and current diagnostic thresholds for the diagnosis of adrenal insufficiency: a single center experience

ea0056p861 | Pituitary - Clinical

An open-label, multicentre, single-arm, expanded-access study of subcutaneous (s.c.) pasireotide in patients with Cushing’s disease (CD)

ea0056p862 | Pituitary - Clinical

Growth hormone secretion in children treated for medulloblastoma

ea0056p863 | Pituitary - Clinical

Interim results of a non-interventional, observational study evaluating the long-term safety and efficacy of pasireotide sc in Cushing’s disease

ea0056p864 | Pituitary - Clinical

An immunohistochemical study on pituitary adenomas

ea0056p865 | Pituitary - Clinical

Inferior petrosal or cavernous sinus sampling in ACTH-dependent Cushing’s syndrome: a single center experience

ea0056p866 | Pituitary - Clinical

Relationship between pituitary adenoma size and transsphenoidal pituitary adenoma surgery outcomes: single-centre experience

ea0056p867 | Pituitary - Clinical

Clinical and mri findings among 120 patients with macroproprolactinemia: results from a retrospective study

ea0056p868 | Pituitary - Clinical

Hypothalamic-pituitary axis assessment in a clozapine treated patient with a pituitary adenoma

ea0056p869 | Pituitary - Clinical

Comorbidities and symptoms among patients with acromegaly in italy: a longitudinal retrospective chart review study

ea0056p870 | Pituitary - Clinical

Safety and efficacy of long-acting Pasireotide monotherapy in acromegalic patients treated with a combination of first-generation somatostatin analogs and cabergoline or pegvisomant

ea0056p871 | Pituitary - Clinical

Association between biochemical control and comorbidities and symptoms among patients with acromegaly in Italy: a longitudinal retrospective chart review study

ea0056p872 | Pituitary - Clinical

Trends of insulin-like growth factor 1, growth hormone, and biochemical control of patients with acromegaly in italy: a longitudinal retrospective chart review study

ea0056p873 | Pituitary - Clinical

Pituitary intensity at magnetic resonance imaging is reduced in obese patients: results from the CHIASM study

ea0056p874 | Pituitary - Clinical

The influence of levothyroxine (T4) treatment on metabolic parameters in central hypothyroidism (CH)

ea0056p875 | Pituitary - Clinical

Efficacy of pasireotide lar in first line somatostatin analogue resistant acromegaly patients: experience from a large and single centre Italian cohort

ea0056p876 | Pituitary - Clinical

The change in metabolic parametres of prolactinoma patients after therapy intervention

ea0056p877 | Pituitary - Clinical

“Silent” ACTH-secreting pituitary carcinoma: case report

ea0056p878 | Pituitary - Clinical

Abstract unavailable

ea0056p879 | Pituitary - Clinical

Radiotherapy for pituitary adenomas – safety and efficacy analysis

ea0056p880 | Pituitary - Clinical

Usefulness of stereotactic radiotherapy in acromegalic patient resistant to conventional treatment

ea0056p881 | Pituitary - Clinical

Subclinical left ventricular dysfunction in patients with naive acromegaly assessed by two-dimensional speckle tracking echocardiography (2D-STE)

ea0056p882 | Pituitary - Clinical

Efficacy and tolerability of cabergoline in a cohort of 160 prolactinomas at weekly doses of up to 9 mg

ea0056p883 | Pituitary - Clinical

Pituitary apoplexy: 15 years of experience

ea0056p884 | Pituitary - Clinical

Clinical and treatment outcomes in patients with craniopharyngiomas – single center experience

ea0056p885 | Pituitary - Clinical

Very high prolactin levels associated to domperidone therapy

ea0056p886 | Pituitary - Clinical

Acromegaly: surgical results and predictors for remission

ea0056p887 | Pituitary - Clinical

Investigation and initial management of hyponatraemia

ea0056p888 | Pituitary - Clinical

Lanreotide autogel may be an effective approach for acromegalic patients who failed octreotide lar

Published by BioScientifica

Endocrine Abstracts
ISSN 1470-3947 (print) | ISSN 1479-6848 (online)
© Bioscientifica 2025 | Privacy policy | Cookie settings

BiosciAbstracts

Bioscientifica Abstracts is the gateway to a series of products that provide a permanent, citable record of abstracts for biomedical and life science conferences.

Find out more